Effects of rifampin on cyclosporine disposition in kidney recipients with tuberculosis.
Kim
Y H
YH
Inje University College of Medicine, Division of Nephrology, Pusan Paik Hospital, South Korea.
Yoon
Y R
YR
Kim
Y W
YW
Shin
J G
JG
Cha
I J
IJ
D000328:Adult; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000502:physiology*; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use*; D018709:Statistics, Nonparametric; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy*
D000904:Antibiotics, Antitubercular; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone; D012293:Rifampin